Day: May 14, 2023
Transaction Values the Company at $1.2 billion
Purchase Price is approximately a 104% premium to the Company’s 3-month volume weighted average stock priceLUXEMBOURG, May 14, 2023 (GLOBE NEWSWIRE) — NeoGames S.A. (Nasdaq: NGMS) (“NeoGames” or the “Company”), a technology-driven provider of end-to-end iLottery and iGaming solutions globally, announced today that it has entered into a definitive Business Combination Agreement (the “Agreement”) to be acquired by Aristocrat Leisure Limited (ASX: ALL) (“Aristocrat”), an entertainment and content creation company delivering world-leading mobile and casino games, for $29.50 per share in an all-cash transaction (the “Transaction”), representing an enterprise value of approximately $1.2 billion for NeoGames.
The transaction price represents a premium of approximately 104%...
Toubani Appoints Senior Mining Executives Scott Perry and Mark Strizek to the Board of Directors
Written by Customer Service on . Posted in Public Companies.
TORONTO, May 14, 2023 (GLOBE NEWSWIRE) — Toubani Resources Inc (ASX:TRE) (“Toubani Resources” or the “Company”) is pleased to announce the appointments of Mr Scott Perry and Mr Mark Strizek to the Board as Non-Executive Directors, effective today. Mr Perry and Mr Strizek are both highly experienced senior mining executives in the industry with a proven track record in corporate initiatives and advancement of development stage assets.
Non-Executive Directors Mr Jan-Erik Back and Mr Doug Jendry are retiring from the Board, effective today. Accordingly, the Toubani Board of Directors now consists of Danny Callow as Executive Chairman, Tim Kestell, Scott Perry and Mark Strizek as Non-Executive Directors, and Phil Russo as Chief Executive Officer and Executive Director. Mr Callow, as previously planned, will transition to Non-Executive...
Athenex, Inc. Reaches Agreement With Lenders to Pursue Expedited Sales Process
Written by Customer Service on . Posted in Public Companies.
To Best Facilitate, Company Voluntarily Files Chapter 11 Proceedings
Company Has Sufficient Resources to Support Athenex Pharma Solutions Operations and Fulfill APD Customer Orders During Process
BUFFALO, N.Y., May 14, 2023 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX) (“Athenex” or the “Company”), a global biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that, following an ongoing strategic review, it has reached agreement with its lenders to move forward with an expedited sales process of the Company’s assets across its primary businesses: Athenex Pharmaceutical Division (“APD”), Orascovery, and Cell Therapy.
To best facilitate this process, Athenex and certain of its subsidiaries filed voluntary...